4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005234
CHIEF ACCOUNTING OFFICER gave up 856 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 704 shares (grant or award)
- CHIEF ACCOUNTING OFFICER acquired 2,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-01-15 | Grant or award | +704 | $9.56 | $6,730 | 8,118 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-03-16 | Option exercise | +774 | 8,892 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-03-16 | Shares withheld for taxes | −221 | $11.46 | $2,533 | 8,671 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-03-20 | Option exercise | +2,163 | 10,834 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-03-20 | Shares withheld for taxes | −635 | $11.12 | $7,061 | 10,199 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-03-16 | Option exercise · Restricted Share Unit | −774 | 1,549 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-03-20 | Option exercise · Restricted Share Unit | −2,163 | 0 | D | ||
Loading xslF345X04/form4-03202023_090305.xml…